Delivery Order SPE2DB20D1100-SPE2DB25FA9P7

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.20 firm fixed-price contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.06, is for the delivery of 10,000 unit vials of the medication Pregnyl. This is a firm fixed-price delivery order contract with an ultimate completion date of April 12, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,447.74 firm fixed-price delivery order is for the supply of 4,564,884,071 vials of Pregnyl 10,000 unit medication. The contract has a period of performance through June 13, 2024 and was awarded on June 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4,564,972,551 units of Pregnyl 10,000 unit vials to the Defense Logistics Agency (DLA). The $2,388.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through June 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order valued at $1,208.70 for the provision of 4,565,020,276 units of Pregnyl (10,000 unit vials). The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.00, is a Delivery Order for the supply of PREGNYL 10,000 UNIT VIALS. The contract has an ultimate completion date of January 27, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA). The $2,002.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, running through November 2026. The IDC enables efficient...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEUS4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a ceiling value of $2,388.96 and a completion date of June 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,784.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,415,725 units of Pregnyl 10,000 unit vials, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a firm fixed-price delivery order. The contract was awarded on October 6, 2023 and does not have a set-aside designation,...
This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA). The contract, a delivery order valued at $1,368.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and an ultimate completion date of October 28, 2024. This contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA9P7
    Delivery Order

This is a $1,155.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a completion date of March 7, 2025.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 6/5/25, 10:01 AM